Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer. [PDF]
Zhao K+7 more
europepmc +1 more source
Targeting CDKs in cancer therapy: advances in PROTACs and molecular glues. [PDF]
Marei HE+7 more
europepmc +1 more source
Cdk1 and Cdk2 activity levels determine the efficiency of replication origin firing in Xenopus
Liliana Krasińska+6 more
openalex +2 more sources
Investigating the molecular mechanisms, drug prediction, and validation of CCNA2 and MAD2L1 in esophageal squamous cell carcinoma based on bioinformatics. [PDF]
Guo C, Wang P, Huang D, Guo J, Liu T.
europepmc +1 more source
From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapy. [PDF]
Xu L, Xiao T, Chao T, Xiong H, Yao W.
europepmc +1 more source
In Silico Network Toxicology, Molecular Docking, and Multi-Level Bioinformatics Reveal Methyl Eugenol-Induced Hepatocellular Carcinoma Mechanisms in Humans. [PDF]
Karakuş F, Tanrıverdi Z, Kuzu B.
europepmc +1 more source
Natural Killer Cell Activation Signature Identifies Cyclin B1/CDK1 as a Druggable Target to Overcome Natural Killer Cell Dysfunction and Tumor Invasiveness in Melanoma. [PDF]
Chen L+10 more
europepmc +1 more source